Search research articles
Contact Us
Filters
Showing results (21-30 of 89) with videos related to
Page
of 9
Sort By:
Hinyokika Kiyo. Acta Urologica Japonica
|
December 29, 2010
[Spontaneous rupture of the ureter as the primary symptom of malignant lymphoma]
Takahiko Yoshii, Akio Horiguchi, Suguru Shirotake, et al.
The Prostate
|
September 18, 2009
Ets-1 and hypoxia inducible factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer
Takeo Kosaka, Akira Miyajima, Suguru Shirotake, et al.
Annals of Surgical Oncology
|
August 9, 2012
Prognostic value of renin-angiotensin system blockade in non-muscle-invasive bladder cancer
Kazuyuki Yuge, Akira Miyajima, Nobuyuki Tanaka, et al.
Cureus
|
December 23, 2024
Initial Experience With Senhance-Assisted Laparoscopic Partial Cystectomy Using the Double Bipolar Method With 3 mm Bipolar Instruments
Junya Kawabata, Go Kaneko, Suguru Shirotake, et al.
Molecular and Clinical Oncology
|
June 8, 2017
Determining the optimum way to maintain quality of life for very elderly patients with advanced bladder cancer and poor performance status: A case report
Kenjiro Suzuki, Fuminari Hanashima, Suguru Shirotake, et al.
Plos One
|
October 20, 2022
Efficacy of abiraterone acetate for high-risk hormone-naïve metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivation therapy alone
Kent Kanao, Takayuki Takahashi, Yuta Umezawa, et al.
Annals of Nuclear Medicine
|
January 5, 2021
Test-retest repeatability of quantitative bone SPECT/CT
Tomohiko Yamane, Kenji Fukushima, Suguru Shirotake, et al.
Molecular and Clinical Oncology
|
April 23, 2019
Meningeal carcinomatosis from bladder cancer: A case report and review of the literature
Yuta Umezawa, Suguru Shirotake, Go Kaneko, et al.
Japanese Journal of Clinical Oncology
|
November 27, 2018
Clinical outcome of high dose rate brachytherapy with external beam radiotherapy for high-risk prostate cancer: a single institutional retrospective study
Suguru Shirotake, Soichi Makino, Kenjiro Suzuki, et al.
Anticancer Research
|
August 2, 2019
Serum Lactate Dehydrogenase Before Nivolumab Treatment Could Be a Therapeutic Prognostic Biomarker for Patients With Metastatic Clear Cell Renal Cell Carcinoma
Suguru Shirotake, Kimiharu Takamatsu, Ryuichi Mizuno, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 89) with videos related to
Sort By:
Page
of 9
Hinyokika Kiyo. Acta Urologica Japonica
|
December 29, 2010
[Spontaneous rupture of the ureter as the primary symptom of malignant lymphoma]
Takahiko Yoshii, Akio Horiguchi, Suguru Shirotake, et al.
The Prostate
|
September 18, 2009
Ets-1 and hypoxia inducible factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer
Takeo Kosaka, Akira Miyajima, Suguru Shirotake, et al.
Annals of Surgical Oncology
|
August 9, 2012
Prognostic value of renin-angiotensin system blockade in non-muscle-invasive bladder cancer
Kazuyuki Yuge, Akira Miyajima, Nobuyuki Tanaka, et al.
Cureus
|
December 23, 2024
Initial Experience With Senhance-Assisted Laparoscopic Partial Cystectomy Using the Double Bipolar Method With 3 mm Bipolar Instruments
Junya Kawabata, Go Kaneko, Suguru Shirotake, et al.
Molecular and Clinical Oncology
|
June 8, 2017
Determining the optimum way to maintain quality of life for very elderly patients with advanced bladder cancer and poor performance status: A case report
Kenjiro Suzuki, Fuminari Hanashima, Suguru Shirotake, et al.
Plos One
|
October 20, 2022
Efficacy of abiraterone acetate for high-risk hormone-naïve metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivation therapy alone
Kent Kanao, Takayuki Takahashi, Yuta Umezawa, et al.
Annals of Nuclear Medicine
|
January 5, 2021
Test-retest repeatability of quantitative bone SPECT/CT
Tomohiko Yamane, Kenji Fukushima, Suguru Shirotake, et al.
Molecular and Clinical Oncology
|
April 23, 2019
Meningeal carcinomatosis from bladder cancer: A case report and review of the literature
Yuta Umezawa, Suguru Shirotake, Go Kaneko, et al.
Japanese Journal of Clinical Oncology
|
November 27, 2018
Clinical outcome of high dose rate brachytherapy with external beam radiotherapy for high-risk prostate cancer: a single institutional retrospective study
Suguru Shirotake, Soichi Makino, Kenjiro Suzuki, et al.
Anticancer Research
|
August 2, 2019
Serum Lactate Dehydrogenase Before Nivolumab Treatment Could Be a Therapeutic Prognostic Biomarker for Patients With Metastatic Clear Cell Renal Cell Carcinoma
Suguru Shirotake, Kimiharu Takamatsu, Ryuichi Mizuno, et al.
Page
of 9